Theranostics Market Outlook: Emerging Technologies and Regional Insights - Major Companies are GE Healthcare, Jubilant Pharmova Limited & Theragnostics Ltd.

The Global Theranostics Market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global theranostics market is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031)

The Theranostics Market is extensively analyzed in the latest study by DataM Intelligence, delivering a well-rounded assessment backed by reliable statistics, historical data, and strategic insights. This report profiles leading industry players, examining their product offerings, pricing strategies, financial health, and growth initiatives. It offers a clear perspective on market dynamics, competitive landscape, and emerging trends that are set to shape the industry's future.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/theranostics-market?rk

Theranostics is a cutting-edge approach in medicine that combines diagnostics and therapeutics into a single treatment strategy. It involves the use of specific biomarkers or diagnostic tests to identify and monitor diseases, followed by personalized treatments based on the information gathered. Theranostics is particularly impactful in areas like cancer treatment, where it enables tailored therapies to target cancer cells more precisely, improving treatment efficacy and minimizing side effects. The goal is to provide individualized medicine for more effective and efficient care.

List of the Key Players in the Theranostics Market:

GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.

Theranostics Industry Development:

February 22, 2022: Theragnostics announced that NephroScan, its radiodiagnostic imaging drug designed to assist in evaluating renal parenchymal disorders in adult and pediatric patients, including term neonates, has received Marketing Approval from the US Food and Drug Administration (FDA).

February 10, 2022: Theragnostics, a company focused on developing radiopharmaceuticals for cancer imaging and treatment, revealed that its novel I-123 PARPi (THG-009) therapeutic agent has been granted an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The approval is for the treatment of primary and recurrent Glioblastoma Multiforme (GBM) under the MHRA's Innovative Licensing and Access Pathway (ILAP), aimed at accelerating the development and access to innovative medicines in the UK.

Research Methodology

Our research methodology combines both qualitative and quantitative approaches to provide you with a thorough market analysis. We begin by gathering data from trusted industry reports and databases (secondary research), followed by primary research through surveys and interviews with key experts. We then apply advanced statistical tools to analyze the data, uncover trends, and assess market dynamics. Additionally, we use market segmentation and Porter's Five Forces analysis to evaluate competition. This approach ensures that the insights we provide are reliable, actionable, and tailored to support your decision-making process.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/theranostics-market

Segment Covered in the Theranostics Market:

By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others

By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others

By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Regional Analysis for Theranostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Theranostics market?

➠ Who are the global key manufacturers of the Theranostics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Theranostics market opportunities and threats faced by the vendors in the global Theranostics Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Theranostics market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.